Target intelligence / Profile preview

Tumor-associated antigen-presenting cells

Molecular classification
Dendritic Cells (DC), Macrophages, B Cells, Immune cells
01

Overview

Tumor-associated antigen-presenting cells (APCs) are immune cells, primarily dendritic cells, macrophages, and B cells, that process and present tumor-derived antigens (TAAs) to T cells. This interaction initiates and shapes anti-tumor immune responses. APCs capture TAAs, process them into peptide fragments, and display these peptides on MHC molecules for T cell recognition, which is crucial for activating cytotoxic CD8+ T cells and helper CD4+ T cells. Dysfunctional APCs or impaired antigen presentation can lead to immune evasion and resistance to therapy, making them important targets for cancer immunotherapy.

Other names
Tumor-associated APCsTAA-presenting cellsCancer antigen-presenting cells
02

Mechanism of action

Priming of T lymphocytes against tumors via MHC presentation of tumor-associated antigens.

03

Biological functions

Antigen presentationT cell activationImmune response initiationCross-presentationInnate immunity bridge to adaptive immunity
04

Disease associations

CancerImmune evasionImmunosuppression
05

Safety considerations

Potential for immune-related adverse eventsTumor escape mechanisms (e.g., downregulation of MHC, antigen masking)
06

Interacting drugs

Cancer vaccines

3 more in the full profile.

07

Biomarkers

Expression levels of MHC Class I/IIExpression levels of antigen processing machinery components (e.g., Proteasome, TAP)

Beyond the preview

Go deeper on Tumor-associated antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor-associated antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call